via Pioneering Minds
A drug molecule “invented” by artificial intelligence (AI) will be used in human trials in a world first for machine learning in medicine.
It was created by British start-up Exscientia and Japanese pharmaceutical firm Sumitomo Dainippon Pharma.
The drug will be used to treat patients who have obsessive-compulsive disorder (OCD).
Typically, drug development takes about five years to get to trial, but the AI drug took just 12 months.
Exscienta chief executive Prof Andrew Hopkins described it as a “key milestone in drug discovery”.
He told the BBC: “We have seen AI for diagnosing patients and for analysing patient data and scans, but this is a direct use of AI in the creation of a new medicine.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
AI designed drug
- AI develops cancer treatment in 30 days, predicts survival rate
Artificial intelligence has developed a treatment for cancer in just 30 days and can predict a patient’s survival rate.
- AI is about to remake the pharmaceutical industry
For years, billions of dollars have been poured into bringing AI into the drug development process. Finally, it seems the cash might be paying off. Medicines designed by AI for conditions including ...
- AI isn’t yet going to take your job — but you may have to work with it
Artificial intelligence is increasingly making its way across industries, changing jobs from retail to medicine to marketing.
- Five Areas Where AI Is Revolutionizing The Biopharmaceutical Industry
With the increasing amount of available data, AI and machine learning have emerged as crucial tools for biopharmaceutical companies looking to remain competitive in the market. These tools are helping ...
- AI ‘used to design entirely new cancer drug within just 30 days’
The AI designed and ‘tested’ the new drug, coming up with an improvement as it did so. In 2022, the AlphaFold computer programme, developed by DeepMind, owned by Google's parent company ...
Go deeper with Google Headlines on:
AI designed drug
[google_news title=”” keyword=”AI designed drug” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Machine learning in medicine
- Using unsupervised machine learning algorithms to classify osteosarcoma
A new editorial paper was published in Oncotarget's Volume 14 on February 11, 2023, entitled, "Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis." ...
- New machine-learning approach identifies one molecule in a billion selectively, with graphene sensors
Graphene's 2D nature, single molecule sensitivity, low noise, and high carrier concentration have generated a lot of interest in its application in gas sensors. However, due to its inherent ...
- Study aims to develop a machine learning model to predict cardiovascular disease using indicators of oral infections
A study aiming to develop and test a machine learning model to predict cardiovascular disease using indicators of oral infections was presented at the 52nd Annual Meeting & Exhibition of the AADOCR, ...
- Consider the Promises and Challenges of Medical Image Analyses Using Machine Learning
Machine learning and AI technology are gaining ground in medical imaging. For many health IT leaders, machine learning is a welcome tool to help manage the growing volume of digital images, reduce ...
- Could Machine Learning Power Up Weak Brain Imaging Studies?
Prior research on brain-wide associated studies has shown that links between brain function and structure and traits are so weak that thousands of participants are needed to detect replicable effects.
Go deeper with Google Headlines on:
Machine learning in medicine
[google_news title=”” keyword=”machine learning in medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
